Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Markham

Showing results (191-200 of 233) with videos related to

Pageof 24
Sort By:
The New England Journal of Medicine|December 12, 1985
Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complexL Resnick, F diMarzo-Veronese, J Schüpbach, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2005
Improved vaccine protection from simian AIDS by the addition of nonstructural simian immunodeficiency virus genesZdenek Hel, Wen-Po Tsai, Elzbieta Tryniszewska, et al.
Science (New York, N.Y.)|October 31, 1986
Isolation of a new virus, HBLV, in patients with lymphoproliferative disordersS Z Salahuddin, D V Ablashi, P D Markham, et al.
AIDS Research and Human Retroviruses|April 9, 1999
CD8+ lymphocyte antiviral activity in monkeys immunized with SIV recombinant poxvirus vaccines: potential role in vaccine efficacyM Leno, L Carter, D J Venzon, et al.
AIDS Research and Human Retroviruses|June 29, 2001
A conformational C4 peptide polymer vaccine coupled with live recombinant vector priming is immunogenic but does not protect against rectal SIV challengeL J Patterson, F Robey, A Muck, et al.
Lancet (London, England)|December 22, 1984
HTLV-III in symptom-free seronegative personsS Z Salahuddin, J E Groopman, P D Markham, et al.
Progress in Allergy|January 1, 1986
HTLV-III and the etiology of AIDSR C Gallo, M G Sarngadharan, M Popovic, et al.
Developments in Biological Standardization|January 1, 1989
Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6)D V Ablashi, P Lusso, C L Hung, et al.
Lancet (London, England)|September 21, 1985
Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivoS Broder, R Yarchoan, J M Collins, et al.
Blood|February 3, 1998
gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection?V Fiorelli, R Gendelman, M C Sirianni, et al.
Pageof 24

Showing results (191-200 of 233) with videos related to

Sort By:
Pageof 24
The New England Journal of Medicine|December 12, 1985
Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complexL Resnick, F diMarzo-Veronese, J Schüpbach, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2005
Improved vaccine protection from simian AIDS by the addition of nonstructural simian immunodeficiency virus genesZdenek Hel, Wen-Po Tsai, Elzbieta Tryniszewska, et al.
Science (New York, N.Y.)|October 31, 1986
Isolation of a new virus, HBLV, in patients with lymphoproliferative disordersS Z Salahuddin, D V Ablashi, P D Markham, et al.
AIDS Research and Human Retroviruses|April 9, 1999
CD8+ lymphocyte antiviral activity in monkeys immunized with SIV recombinant poxvirus vaccines: potential role in vaccine efficacyM Leno, L Carter, D J Venzon, et al.
AIDS Research and Human Retroviruses|June 29, 2001
A conformational C4 peptide polymer vaccine coupled with live recombinant vector priming is immunogenic but does not protect against rectal SIV challengeL J Patterson, F Robey, A Muck, et al.
Lancet (London, England)|December 22, 1984
HTLV-III in symptom-free seronegative personsS Z Salahuddin, J E Groopman, P D Markham, et al.
Progress in Allergy|January 1, 1986
HTLV-III and the etiology of AIDSR C Gallo, M G Sarngadharan, M Popovic, et al.
Developments in Biological Standardization|January 1, 1989
Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6)D V Ablashi, P Lusso, C L Hung, et al.
Lancet (London, England)|September 21, 1985
Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivoS Broder, R Yarchoan, J M Collins, et al.
Blood|February 3, 1998
gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection?V Fiorelli, R Gendelman, M C Sirianni, et al.
Pageof 24